Jeremy M. Clain

发表

Novel Treatments for Drug-Resistant Tuberculosis:

P. Escalante, J. Clain, Jeremy M. Clain, 2016 .

Diagnosis of NTM Disease: Pulmonary and Extrapulmonary

T. Aksamit, J. Clain, Jeremy M. Clain, 2018, Nontuberculous Mycobacterial Disease.

Clinical and Epidemiological Correlates of Low IFN-Gamma Responses in Mitogen Tube of QuantiFERON Assay in Tuberculosis Infection Screening During the COVID-19 Pandemic: A Population-Based Marker of COVID-19 Mortality?

M. Balbín, P. Escalante, J. García-García, 2022, Archivos de Bronconeumología.

Glucose control in critical care.

K. Ramar, S. Surani, J. Clain, 2015, World journal of diabetes.

Non-antimicrobial airway management of non-cystic fibrosis bronchiectasis

P. Escalante, A. Egan, J. Clain, 2017, Journal of clinical tuberculosis and other mycobacterial diseases.

MAJOR INVESTIGATIONS OF GLYCEMIC CONTROL IN CRITICALLY ILL PATIENTS

K. Ramar, S. Surani, J. Clain, 2015 .

Cystatin C Falsely Underestimated GFR in a Critically Ill Patient with a New Diagnosis of AIDS

K. Kashani, E. Frazee, Caitlin S. Brown, 2016, Case reports in nephrology.

Physiology and Pathophysiology of Sleep Apnea Transition from acute to chronic hypercapnia in patients with periodic breathing : predictions from a computer model

D. Rapoport, R. Norman, K. Berger, 2006 .

Experience with rituximab in the treatment of antineutrophil cytoplasmic antibody associated vasculitis

U. Specks, R. Cartin-Ceba, F. Fervenza, 2014, Therapeutic advances in musculoskeletal disease.

Biologic response modifiers for granulomatosis with polyangiitis (Wegener's): from promise to reality

U. Specks, R. Cartin-Ceba, J. Clain, 2013 .

S1. Rituximab for ANCA-associated vasculitis: the experience in the United States.

U. Specks, J. Clain, Jeremy M. Clain, 2013, Presse medicale.